Stockreport

Myovant Sciences Announces Publication of Abstracts Detailing Additional Efficacy and Safety Findings from Phase 3 LIBERTY Studies in Uterine Fibroids in Obstetrics & Gynecology

Myovant Sciences Ltd. Common Shares  (MYOV) 
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am Check Earnings Report
US:NYSE Investor Relations: investors.myovant.com
PDF Abstracts accepted for presentation in oral and poster sessions at the 2020 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Mee [Read more]